Inactive Instrument

Canna-V-Cell Sciences Inc Stock Canadian Securities Exchange

Equities

CA5980011053

Fishing & Farming

Sales 2021 2.1M 2.88M Sales 2022 5.5M 7.52M Capitalization 98.54M 135M
Net income 2021 -9M -12.31M Net income 2022 -11M -15.05M EV / Sales 2021 77.8 x
Net cash position 2021 1.46M 1.99M Net Debt 2022 8.82M 12.07M EV / Sales 2022 19.5 x
P/E ratio 2021
-16.1 x
P/E ratio 2022
-8.7 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
BioHarvest Sciences : Reaches Milestone in Scale-Up of Cannabis Development Program MT
BioHarvest Sciences : Closes First Tranche of Private Placement MT
Bioharvest Sciences Inc. Unveils New Groundbreaking Cannabis Trichome Structure CI
BioHarvest Sciences : Up 2.5% after Reporting Board Approval for Private Placement MT
BioHarvest Sciences : Rises 8% as Reports Record Q2 Sales Orders MT
BioHarvest Sciences Inc. Announces Sales Results for the Second Quarter of 2021 CI
BioHarvest Sciences Inc. Reveals Vinia Anti-Aging Capabilities Via Blood Flow Improvement CI
BioHarvest Sciences Inc. Reports Earnings Results for the First quarter Ended March 31, 2021 CI
Canna-V-Cell Sciences Inc. Reports Earnings Results for the Third Quarter Ended January 31, 2020 CI
BioHarvest Ltd. completed the acquisition of Canna-V-Cell Sciences Inc. in a reverse merger transaction. CI
Canna-V-Cell Sciences Inc. Reports Earnings Results for the Second Quarter Ended October 31, 2019 CI
BioHarvest Ltd. entered into an agreement to acquire Canna-V-Cell Sciences Inc. in a reverse merger transaction. CI
Canna-V-Cell Sciences Inc. Announces Stable Production of Cannabis Cells, Trichomes, and Cannabinoids Without the Need to Grow the Cannabis Plant Itself CI
Canna-V-Cell Sciences Inc. announced that it has received CAD 1 million in funding CI
Canna-V-Cell Sciences Inc. Reports Earnings Results for the Full Year Ended April 30, 2019 CI
More news
Canna-V-Cell Sciences Inc, formerly known as Midnight Star Ventures Corp, is a Canada-based company engaged in cannabis business sector. The Company through its subsidiary Dolarin Ltd is focused on development of biofarming technology for cannabis.
More about the company